Skip to main content
. Author manuscript; available in PMC: 2016 Jan 31.
Published in final edited form as: J Biomed Mater Res A. 2014 May 7;103(2):574–580. doi: 10.1002/jbm.a.35200

Figure 5.

Figure 5

Interaction diagram showing the differences in mean decay time constant by group. There were significant differences between TGF-β1 treated CTS patient and control cells (*, p<0.05) but not between cell type and TGF-β1 treatment type.